Number of the records: 1
Dendritic-cell vaccine (DCVAC) with first line chemotherapy in patients with stage IV NSCLC primary analysis of phase 2, open-label, randomized, multicenter trial
SYS 0506294 LBL 01000a^^22220027750^450 005 20220624154457.0 017 $a 10.1200/JCO.2018.36.15_suppl.9051 $2 DOI 100 $a 20190713d m y slo 03 ba 101 $a eng 200 1-
$a Dendritic-cell vaccine (DCVAC) with first line chemotherapy in patients with stage IV NSCLC primary analysis of phase 2, open-label, randomized, multicenter trial 463 -1
$1 001 cav_un_epca*0253654 $1 011 $a 0732-183X $e 1527-7755 $1 200 1 $a Journal of Clinical Oncology $v Roč. 36, 15 suppl (2018), s. 9051-9051 700 -1
$3 cav_un_auth*0016884 $a Havel $b L. $y CZ 701 -1
$3 cav_un_auth*0020286 $a Zemanová $b M. $y CZ 701 -1
$3 cav_un_auth*0207641 $a Pešek $b M. $y CZ 701 -1
$3 cav_un_auth*0247428 $a Kolek $b V. $y CZ 701 -1
$3 cav_un_auth*0202485 $a Spíšek $b R. $y CZ 701 -1
$3 cav_un_auth*0035868 $a Bartůňková $b J. $y CZ 701 -1
$3 cav_un_auth*0100801 $a Pecen $b Ladislav $p UIVT-O $i Oddělení statistického modelování $j Department of Statistical Modelling $w Department of Statistical Modelling $T Ústav informatiky AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0376960 $a Krasnopolskaya $b I. $y CZ 701 -1
$3 cav_un_auth*0376961 $a Černovská $b M. $y CZ
Number of the records: 1